The genetic contribution to a number of neurological disorders is thought to be complex in nature, disease risk being driven by a combination of """"""""risk"""""""" alleles commonly present in the human genome. Recently the completion of stages I and II of the international Haplotype Map project and the availability of high-plex SNP assays has made genome wide assay of common genetic variability a realistic endeavor. We are applying genome wide association analysis usign ~500,000SNPs to disease and non-disease cohorts, these include cohorts with Parkinson's disease, Stroke, Amyotrophic Lateral Sclerosis and also neurologically normal controls, all from the NINDS funded neurogenetics repository. We have developed and implemented the necessary hardware and software infrastructure to store and manipulate the ~2 billion datapoints associated with these experiments. To data the experiments analysing Parkinson's disease are complete and have recently been published. THese data show that there is no single common genetic variant that has a major influence in risk for Parkinson's disease in the North American Caucasian population. We have posted these data on an open access website ( for mining and augmentation by other interested researchers.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Intramural Research (Z01)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
United States
Zip Code
Nicolas, Aude (see original citation for additional authors) (2018) Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 97:1268-1283.e6
Burciu, Roxana G; Seidler, Rachael D; Shukla, Priyank et al. (2018) Multimodal neuroimaging and behavioral assessment of ?-synuclein polymorphism rs356219 in older adults. Neurobiol Aging 66:32-39
Blauwendraat, Cornelis; Kia, Demis A; Pihlstrøm, Lasse et al. (2018) Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease. Neurobiol Aging 64:159.e5-159.e8
Agrawal, A; Chou, Y-L; Carey, C E et al. (2018) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry 23:1293-1302
Juge, Pierre-Antoine; Lee, Joyce S; Ebstein, Esther et al. (2018) MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease. N Engl J Med 379:2209-2219
Chen, Xi; Scholz, Sonja W (2018) Identification of new ?-synuclein regulator by nontraditional drug development pipeline. Mov Disord 33:402
Jansen, Iris E; Gibbs, J Raphael; Nalls, Mike A et al. (2017) Establishing the role of rare coding variants in known Parkinson's disease risk loci. Neurobiol Aging 59:220.e11-220.e18
Blauwendraat, Cornelis; Bandrés-Ciga, Sara; Singleton, Andrew B (2017) Predicting progression in patients with Parkinson's disease. Lancet Neurol 16:860-862
Caress, James B; Johnson, Janel O; Abramzon, Yevgeniya A et al. (2017) Exome sequencing establishes a gelsolin mutation as the cause of inherited bulbar-onset neuropathy. Muscle Nerve 56:1001-1005
Gendron, Tania F; Chew, Jeannie; Stankowski, Jeannette N et al. (2017) Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Sci Transl Med 9:

Showing the most recent 10 out of 138 publications